The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

Clinical trial NCT04372615 · RECRUITING

Trial details

NCT number: NCT04372615
Sponsor: University of Utah
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autoimmune Encephalitis Encephalitis

Start date: 2022-03-30
Primary completion: 2028-09-30
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.